Does A Lesion On The Prostate Mean Cancer?

Medically reviewed by Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

Does a lesion on the prostate mean cancer? No — not automatically. A prostate lesion found on MRI is a common finding, and most turn out to be benign, the result of inflammation, a cyst, or normal tissue variation rather than cancer. Understanding what a lesion actually means, and what happens next, is the most important step you can take.

Key Takeaways

  • A prostate lesion on MRI does not automatically mean cancer
  • Most lesions are benign — caused by inflammation, BPH, or normal tissue variation
  • PI-RADS scores 1 to 2 are very unlikely to indicate significant cancer
  • PI-RADS 4 or 5 warrants further investigation but still does not confirm cancer
  • A specialist can review your results and advise on next steps, often within days

What is a prostate lesion?

A lesion simply refers to any area of tissue that looks different from the surrounding tissue on an MRI scan. In the prostate, lesions can be caused by a number of conditions that have nothing to do with cancer, including prostatitis (inflammation of the prostate), benign prostatic hyperplasia (BPH), calcifications, and cysts.

The finding of a lesion does not, on its own, indicate cancer. It means the area needs to be looked at more closely — usually by assessing it against your PSA level, symptoms, age, and family history. Whether a lesion on the prostate means cancer depends entirely on the full clinical picture, not the MRI finding alone.

When might a lesion on the prostate mean cancer?

Although most prostate lesions are not dangerous, some can suggest the presence of cancer. To assess this, doctors use a multiparametric MRI (mpMRI) alongside a scoring system called PI-RADS (Prostate Imaging Reporting and Data System), which rates lesions from 1 to 5. This scoring system is the primary tool specialists use to answer whether a lesion on the prostate means cancer is likely.

PI-RADS Score What it means
1 to 2 Very unlikely to be clinically significant cancer
3 Indeterminate — further clinical context needed alongside PSA and symptoms
4 Likely to be clinically significant — targeted biopsy is often recommended
5 Highly likely to be clinically significant — biopsy is strongly recommended

A score of 4 or 5 does not confirm cancer. It means the lesion warrants closer investigation. A targeted MRI-guided biopsy is the usual next step, and results from this are far more accurate than older biopsy methods. If you have received a PI-RADS score and are waiting for guidance, a private consultation with Mr Ghei can clarify your options quickly and without a long wait.

Related read: What Not To Do Before A PSA Blood Test

Private Prostate MRI Review London

A prostate lesion does not automatically mean cancer. Get your results reviewed by a specialist.

Mr Ghei can review your MRI results and explain exactly what they mean for you, in plain language, with a clear recommendation on next steps. Most patients are seen within days of enquiry. Consultations from £250.

How prostate lesions are investigated

If an MRI shows a lesion that warrants further investigation, the next step is usually a targeted biopsy. Unlike older transrectal biopsies, modern MRI-guided transperineal biopsies are more accurate, carry a lower risk of infection, and can be performed under local or general anaesthetic. Mr Ghei performs transperineal biopsies at his London hospitals and can advise on which approach is right for you.

It is worth noting that according to NHS guidance on prostate cancer diagnosis, not every lesion seen on MRI leads to a biopsy recommendation — the decision depends on your full clinical picture.

Managing worry after finding a lesion

It is entirely normal to feel anxious after receiving an MRI report that mentions a lesion. The language used in radiology reports can be alarming even when the findings are relatively reassuring. Many men asking whether a lesion on the prostate means cancer find that speaking with a specialist — rather than waiting for an NHS appointment or searching online — significantly reduces their anxiety and helps them understand what, if anything, needs to happen next.

What to do after a prostate lesion is found

If you have recently received an MRI report showing a lesion, the most useful thing you can do is have it reviewed by a consultant urologist as soon as possible. A specialist will:

  • Explain your PI-RADS score and what it means for your specific situation
  • Review your PSA result in the context of your age, ethnicity and family history
  • Advise whether a biopsy is needed or whether active monitoring is the right approach
  • Give you a clear timeline and next steps, in plain language

Many men find that getting a clear explanation from a specialist is the most important step in reducing anxiety. Knowing exactly where you stand, and what happens next, is far better than waiting and worrying.

Mr Maneesh Ghei sees new patients privately with same-week availability. No GP referral is required. Book a consultation online or call 020 3325 4699.

Frequently Asked Questions

Does a lesion on the prostate mean cancer?

No. Most prostate lesions are benign findings caused by inflammation, BPH, or normal tissue variation. Whether a lesion on the prostate means cancer depends on its appearance on MRI (its PI-RADS score), your PSA level, symptoms, and family history. A specialist review will give you a clear answer.

What does a prostate lesion on MRI look like?

Radiologists describe lesions by their location (peripheral zone or transition zone), size, and how they appear on different MRI sequences. The PI-RADS scoring system translates these observations into a risk score from 1 to 5.

Is a PI-RADS 3 lesion dangerous?

PI-RADS 3 is classed as indeterminate. It means the lesion could be significant but equally could be benign. A specialist will usually look at your PSA, symptoms, and history to decide whether a biopsy is warranted or whether active monitoring is more appropriate.

Can a prostate lesion disappear on its own?

Some lesions, particularly those caused by prostatitis, can reduce or resolve with treatment. Lesions caused by BPH or calcifications may remain present on future scans without causing any problems.

How long does it take to get biopsy results after a prostate lesion is found?

NHS waiting times vary, but biopsy results are typically available within two to four weeks. With a private biopsy through Mr Ghei, results are usually returned within one to two weeks.

Do I need a GP referral to get my prostate lesion reviewed privately?

No. Mr Ghei accepts self-referrals. You can book a consultation directly online or by calling the clinic. You do not need to wait for your GP to refer you.

About the Author

Mr Maneesh Ghei, Consultant Urological Surgeon

Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

Mr Maneesh Ghei is a consultant urological surgeon with NHS and private practice across four London hospitals. He specialises in the diagnosis and management of prostate conditions including BPH, prostatitis and prostate cancer, as well as urinary symptoms, kidney stones and male sexual health. Mr Ghei sees new patients privately with same-week availability. No GP referral is required. Book a prostate screening consultation.

Need help to book a consultation or got an enquiry regarding what tests you may need?

Fill in your details and we will contact you

🔒 Your data is secure. We’ll only use it to arrange your appointment.

Picture of Maneesh Ghei
Maneesh Ghei
Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.
Scroll to Top